other brands of tirzepatide Lilly's Weight-Loss Drug Approved in China Amid Race With Novo Tirzepatide – 60 mg Vial

Health Conditions A-Z Health & Wellness Nutrition Fitness Health News Ayurveda Videos Medicine A-Z Parenting Login to get the latest articles, videos, gallery, and a lot more or continue with Email Google Facebook To get Registered Signup now Credit: iStock/Wegovy Rachel V Thomas Updated Jul 20, 2026 | 10:24 AM IST Summary Novo Nordisk said that Wegovy is the first and only GLP-1 receptor agonist (GLP-1 RA) approved globally and in India for the treatment of noncirrhotic MASH in adults with moderate to advanced liver fibrosis, alongside a reduced-calorie diet and increased physical activity

This is the clinical reality behind LIV Body's "Muscle Guard" nutritional strategy positioning - the brand describes it as designed to support lean-mass maintenance

Development of a clinical trials version of the Impact of Weight on Quality of Life-Lite questionnaire (IWQOL-Lite Clinical Trials Version): results from two qualitative studies

Adequate hydration (at minimum 64 ounces per day), fiber supplementation, and regular movement help keep things moving